ARTICLE | Company News
FOB Synthesis, AstraZeneca deal
February 3, 2014 8:00 AM UTC
FOB partnered with AstraZeneca to develop combinations of preclinical carbapenem formulations from FOB with undisclosed preclinical beta lactamase (LACTB) inhibitors from AstraZeneca for multidrug-re...